Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 2Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 2Classical hematology 1

Conditions

Myelodysplastic Syndromes 243Leukemia, Myeloid, Acute 191Leukemia 145Leukemia, Myelogenous, Chronic, BCR-ABL Positive 139Precursor Cell Lymphoblastic Leukemia-Lymphoma 120Myeloproliferative Disorders 89Multiple Myeloma 84Leukemia, Lymphocytic, Chronic, B-Cell 78Lymphoma, Non-Hodgkin 76Primary Myelofibrosis 72Leukemia, Myelomonocytic, Chronic 68Lymphoma 67Hodgkin Disease 66Leukemia, Myeloid, Chronic-Phase 55Lymphoma, Mantle-Cell 50Blast Crisis 49Lymphoma, Large B-Cell, Diffuse 47Lymphoma, Follicular 44Leukemia, Myeloid, Accelerated Phase 44Congenital Abnormalities 41Lymphoma, B-Cell, Marginal Zone 40Burkitt Lymphoma 40Neoplasms, Plasma Cell 38Lymphoma, Large-Cell, Immunoblastic 35Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 35Polycythemia Vera 32Hematologic Neoplasms 31Myelodysplastic-Myeloproliferative Diseases 30Lymphoma, T-Cell, Cutaneous 29Anemia, Refractory, with Excess of Blasts 29

Interventions

N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 111-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Hemorrhagic Disorders × Myeloid × Clear all
NCT02055781 2021-11-18

PAC326

CTI BioPharma

Phase 3 Terminated
311 enrolled 12 charts
Classical hematologyMyeloid

Anemia, Bone Marrow Diseases, Hematologic Diseases, Hemorrhagic Disorders, Myeloproliferative Disorders, Polycythemia Vera, Splenomegaly, Thrombocythemia, Essential, Thrombocytopenia, Primary Myelofibrosis

NCT01998828 2020-04-20

Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia

Sierra Oncology LLC - a GSK company

Phase 2 Terminated
39 enrolled
Myeloid

Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, Hematologic Diseases, Hemorrhagic Disorders, Myeloproliferative Disorders, Polycythemia, Polycythemia Vera, Thrombocythemia, Essential, Thrombocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡